Hologic, Inc. reports corporate-status and women’s health medical-technology developments following its acquisition by funds managed by Blackstone and TPG, which established Hologic as a private company. Its news has covered the completed transaction, governance changes, operating and financial results, and capital-structure matters tied to the former Nasdaq-listed common stock.
Company updates also describe Hologic’s diagnostics and cervical-health portfolio, including the Aptima HPV Assay, ThinPrep Pap Test and Genius Digital Diagnostics System, as well as public-health initiatives such as the Hologic Global Women’s Health Index and screening-awareness campaigns.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.